Non–AIDS-Defining Cancers

  • Authors: David Aboulafia, MD (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 11/15/21 (What's New)

Summary

  • 5-year survival rate for persons with HIV and invasive anal cancer earlier in HAART era: 47%[Bower 2004]
    • Later HAART era study demonstrated 70% 5-year OS rate in persons with HIV with invasive anal canal cancer vs 69% in matched controls[Oehler-Jänne 2006]
    • OS negatively associated with high HIV-1 RNA level and low CD4+ cell count

Action required

Keywords: Cancer, Sexually Transmitted Diseases

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.